Completed Epilepsy trials in Russia: Trial Insights

Filters: Condition: Epilepsy Status: Completed Country / region: Russia Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2004	4
2005	5
2006	3
2007	6
2008	2
2010	4
2011	4
2012	3
2013	3
2014	3
2015	3
2016	1
2018	1
2020	1

Trials by status
Category	Trials
Completed	43

Top lead sponsors
Category	Trials
UCB Pharma	9
GlaxoSmithKline	6
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	5
UCB BIOSCIENCES, Inc.	5
Eisai Inc.	3
Marinus Pharmaceuticals	2
Novartis	2
UCB BIOSCIENCES GmbH	2
Upsher-Smith Laboratories	2
Bial - Portela C S.A.	1

Top conditions
Category	Trials
Epilepsy	43
Seizures	18
Epilepsies, Partial	9
Epilepsy, Tonic-Clonic	2
Epilepsy, Complex Partial	1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy NCT04252846ObservationalCompletedEisai LimitedStarted 2020
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder NCT03572933Phase 3CompletedMarinus PharmaceuticalsStarted 2018
A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994 NCT02582866Phase 3CompletedUCB Biopharma S.P.R.L.Started 2016
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures NCT02408549Phase 3CompletedUCB BIOSCIENCES, Inc.Started 2015
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures NCT02477839Phase 3CompletedUCB BIOSCIENCES, Inc.Started 2015
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications NCT02408523Phase 3CompletedUCB BIOSCIENCES, Inc.Started 2015
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy NCT02201251Phase 3CompletedJanssen Research & Development, LLCStarted 2014
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. NCT02072824Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2014
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures NCT01964560Phase 3CompletedUCB BIOSCIENCES, Inc.Started 2014
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension NCT01963208Phase 3CompletedMarinus PharmaceuticalsStarted 2013
Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures NCT01921205Phase 3CompletedUCB PharmaStarted 2013
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. NCT01747915Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2013
Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older NCT01465997Phase 3CompletedUCB BIOSCIENCES GmbHStarted 2012
Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures NCT01749046Phase 3CompletedValexfarmStarted 2012
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures NCT01463306Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2012
Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy NCT01339559Phase 3CompletedUCB BIOSCIENCES, Inc.Started 2011
Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older NCT01243177Phase 3CompletedUCB BIOSCIENCES GmbHStarted 2011
Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) NCT01336621Phase 3CompletedGlaxoSmithKlineStarted 2011
Once-A-Day Pregabalin For Partial Seizures NCT01262677Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.Started 2011
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures NCT01261325Phase 3CompletedUCB PharmaStarted 2010
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures NCT01191086Phase 3CompletedUpsher-Smith LaboratoriesStarted 2010
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures NCT01227902Phase 3CompletedGlaxoSmithKlineStarted 2010
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures NCT01142193Phase 3CompletedUpsher-Smith LaboratoriesStarted 2010
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures NCT00735397Phase 3CompletedEisai Inc.Started 2008
Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures NCT00848549Phase 3CompletedEisai Inc.Started 2008

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory